Posted by Michael Wonder on 17 Jun 2021
FDA approves a nasal anti-histamine for non-prescription use
17 June 2021 - The U.S. FDA today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.
The FDA approved Astepro (azelastine hydrochloride 0.15% nasal spray) for seasonal and perennial allergic rhinitis—commonly known as allergies—for adults and children six years of age and older.
